🇺🇸 FDA
Patent

US 11524955

2,4-diamino-pyrimidine compounds and method for making and using the compounds

granted A61PA61P11/06A61P13/00

Quick answer

US patent 11524955 (2,4-diamino-pyrimidine compounds and method for making and using the compounds) held by Rigel Pharmaceuticals, Inc. expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P11/06, A61P13/00, A61P25/00, A61P29/00